BRLI News Alert Bio-Reference Laboratories (BRLI) 31.82 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Reference Laboratories (BRLI) 31.82 $BRLI

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BRLI: 31.82 (+0.55), AXGN: 3.85 (+0.17), AZPN: 36.69 (+0.28), ARQL: 1.15 (+0.01), ADUS: 23.80 (-0.19)

Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Dec 18, 3:55PM CST

BRLI: 31.82 (+0.55)

BioReference Laboratories, Inc. Announces Quarterly and Yearly Record Revenues, Net Income and Patient Volumes
GlobeNewswire - Thu Dec 18, 11:56AM CST
Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces record fourth quarter and full fiscal year results for revenues, net income and patient volumes. Except for per share data or where otherwise noted, numbers are in thousands.
BRLI: 31.82 (+0.55)

Bio-Reference Laboratories (BRLI) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Dec 18, 9:25AM CST

BRLI: 31.82 (+0.55)

BioReference Lab ups earnings 65% in FQ4
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 7:53AM CST

BRLI: 31.82 (+0.55)

Bio-Reference Laboratories posts 4Q profit
Automated Insights - Thu Dec 18, 7:39AM CST
ELMWOOD PARK, N.J. (AP) _ Bio-Reference Laboratories Inc. (BRLI) on Thursday reported earnings of $18.3 million, or 66 cents per share, in its fiscal fourth quarter.
BRLI: 31.82 (+0.55)

Bio-Reference Lab beats by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 7:33AM CST

BRLI: 31.82 (+0.55)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 4:30PM CST

WGO: 22.64 (+0.25), SCHL: 35.39 (+0.07), BRLI: 31.82 (+0.55), CAG: 36.86 (-0.07), SAFM: 84.54 (+0.26), ATU: 27.21 (+0.03), WOR: 30.41 (+0.34), NEOG: 48.21 (-0.10), ACN: 91.32 (-0.10), RAD: 7.26 (-0.09)

5 Earnings Short-Squeeze Plays: BlackBerry, Pier 1 and More
at The Street - Tue Dec 16, 11:39AM CST
You only need to find a few of these stocks in a year to juice your portfolio returns.
WGO: 22.64 (+0.25), SCHL: 35.39 (+0.07), BRLI: 31.82 (+0.55), PIR: 15.33 (-0.11), BBRY: 10.67 (-0.13)

United States Medical Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lncwzs/medical) has announced the addition of Plunkett Research Ltd's new report "Medical Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical Laboratories Industry (U.S.) to reach $218.2 billion by 2021. - Medical Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - Medytox Solutions Inc - NeoGenomics Inc - Psychemedics Corporation - Quest Diagnostics Inc For more information visit http://www.researchandmarkets.com/research/lncwzs/medical Source: Plunkett Research Ltd
PMD: 14.90 (+0.05), HH: 0.53 (unch), BRLI: 31.82 (+0.55), NEO: 4.03 (-0.10), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), GHDX: 32.44 (+1.32)

United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.53 (unch), BRLI: 31.82 (+0.55), RDNT: 9.41 (-0.08), NEO: 4.03 (-0.10), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), GHDX: 32.44 (+1.32)

BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014
GlobeNewswire - Thu Dec 11, 7:56AM CST
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for 2014 before the open of market trading on Thursday, December 18, 2014. The Company's earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
BRLI: 31.82 (+0.55)

Bio-Reference Laboratories Tested: Undisclosed Lawsuit Alleges Fraud, Ex-Employees Speak Out
The GeoTeam - Seeking Alpha - Wed Dec 10, 9:15AM CST
By now, some of the extremely obvious risks to investing in Bio-Reference Laboratories (NASDAQ: BRLI ) have been in the public domain for a while. Questions have been raised about ties to organized crime, stuffing envelopes full of cash for...
BRLI: 31.82 (+0.55), DGX: 67.94 (-0.16), LH: 107.69 (+0.56)

Bear of the Day: Invacare Corp (IVC) - Bear of the Day
Brian Hamilton - ZACKS - Mon Nov 24, 12:00AM CST
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
BRLI: 31.82 (+0.55), IVC: 16.80 (+0.20), STE: 66.76 (+0.85), MMSI: 17.17 (+0.01)

CR Bard (BCR) Scales 52-Week High on Strong Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 12:10PM CST
Impressive third-quarter 2014 results reflecting double-digit bottom-line growth, the recent FDA approval for its Lutonix DCB along with a robust product pipeline contribute to the growth trajectory of this company.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), STE: 66.76 (+0.85)

DENTSPLY (XRAY) Hits New 52-Week High on Q3 Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 10:40AM CST
DENTSPLY International Inc. (XRAY) continues to execute on its overall growth strategy via margin expansion, better asset utilization and product innovation.
ABC: 91.60 (+0.18), BRLI: 31.82 (+0.55), STE: 66.76 (+0.85), XRAY: 53.76 (-0.24)

MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:00AM CST
MWI Veterinary's (MWIV) share price has declined 8.7% since the announcement of the fourth quarter results to close at $155.00 yesterday.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), MWIV: 172.76 (-0.28)

Henry Schein Tops Q3 Earnings, Revenues; Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:30AM CST
Henry Schein's (HSIC) share price jumped 6.1% to eventually close at $129.62 yesterday.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), HSIC: 137.87 (+0.15)

Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 9:10AM CST
Following the earnings release, Steris' (STE) share price rose 1.9% to eventually close at $63.64 yesterday.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), STE: 66.76 (+0.85)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 104

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 107

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 81

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 79

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading

Top 5 Most Recently Viewed Articles

Larry Chen's Transformative Journey in Automotive Photography

Updated Category News Views 460

Celebrating 20 Years of Automotive Photography Renowned automotive photographer Larry Chen presents his first-ever book titled Life at Shutter Speed: Two Decades of Larry Chen Photography. This extensive 400-page work features exceptional highlights from Chen's impressive career, along with captivating never-before-seen images. What’s Inside the Book? Life at Shutter...

Continue Reading
Kemper Corporation Achieves Record Stock High of $71.71

Updated Category News Views 157

Kemper Corporation Achieves New Stock Milestone Kemper Corporation (NYSE: KMPR) has reached an impressive milestone by achieving a remarkable 52-week high of $71.71. This achievement not only signifies a substantial uptrend for the diversified insurance holding but also reflects a commendable 67.95% increase in its stock value over the past year. The rising confidence...

Continue Reading
Rising Online Vaping Markets: A Challenge for Local Stores

Updated Category News Views 114

Challenges Faced by Local Convenience Stores in Quebec Local convenience stores in Quebec are confronting significant challenges due to the rise of online vaping sales. As these businesses grapple with a ban on flavored vapor products, introduced by Health Minister Christian Dubé, they are witnessing a shift in consumer behavior. This change has driven many customers to...

Continue Reading
Krispy Kreme Shareholders Invited to Join Class Action Lawsuit

Updated Category News Views 485

Krispy Kreme Investors: The Class Action Lawsuit Explained Krispy Kreme, Inc. (NASDAQ: DNUT) is facing a class action lawsuit that is generating significant attention among investors. This suit has been initiated by Robbins LLP following concerns about misleading statements made by the company's executives regarding its partnership with McDonald's. For anyone invested in...

Continue Reading
DexCom, Inc. Class Action Notice: Your Chance to Join Efforts

Updated Category News Views 62

Important Warning for DexCom, Inc. Shareholders Investors holding shares of DexCom, Inc. (NASDAQ: DXCM) should be aware of a critical opportunity to engage in a class action lawsuit. This notice emphasizes the essential details for shareholders who purchased shares during the specified class period. Your Participation Matters Shareholders are urged to reach out promptly...

Continue Reading